Search results
Icahn Enterprises L.P. Announces Closing of $750 Million Senior Notes Offering
FOX 4 Kansas City· 6 days agoIcahn Enterprises L.P. (NASDAQ: IEP) – Icahn Enterprises L.P. ("Icahn Enterprises") announced today...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 6 days agoImmunic to Participate in Industry and Scientific Conferences in June PR Newswire NEW YORK, May 28, 2024 NEW YORK, May 28, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology ...
OTR: Mass. congressman says Trump's conviction raises stakes of 2024 election
WCVB Boston· 1 day agoCONGRESSMAN SETH MOULTON IS OUR GUEST THIS MORNING. THE CONGRESSMAN IS IN THE CHAIR. AS YOU CAN SEE...
EMEA Morning Briefing: Shares Set to Gain Amid Rate-Cut Hopes
Morningstar· 14 hours agoMARKET WRAPS Watch For: Manufacturing PMI for EU, Germany, France, Italy, UK; no major corporate updates expected Opening Call: Shares are poised to start higher in Europe ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 6 days agoWYNDHAM HOTELS & RESORTS COMPLETES SUCCESSFUL DEBT REPRICING AND UPSIZING PR Newswire PARSIPPANY, N.J., May 28, 2024 PARSIPPANY, N.J., May 28, 2024 /PRNewswire/ -- Wyndham Hotels & Resorts, ...
On-the-Record Press Gaggle by White House National Security Communications Advisor John Kirby | The...
The White House· 5 days agoToday, the Secretary of the Army is in Mesquite, Texas, for the opening of a new factory that will...
The Motley Fool: Try on Nike stock for size
Dallas Morning News· 1 day agoNike stock slumped after its third-quarter earnings report, which featured weak revenue growth and disappointing projections. The stock’s value has...
Affimed Receives Fast Track Designation for Combination Therapy of AFM24 with Atezolizumab for EGFR...
Morningstar· 5 days agoEfficacy and safety of AFM24 in combination with atezolizumab, a checkpoint inhibitor, is being evaluated in non-small cell lung cancer patients with EGFR wild-type and EGFR mutant advanced/ ...
Affimed Provides Follow-up Data of AFM24 plus Atezolizumab Showing Durable Responses in Heavily...
Morningstar· 2 days agoIn 17 EGFR wild-type (EGFRwt) non-small cell lung cancer (NSCLC) patients who failed chemotherapy and PD-1/PD-L1, AFM24 plus atezolizumab achieved 4 objective responses; 3 of 4 responses were ...
Veeva Announces Fiscal 2025 First Quarter Results
Yucaipa News Mirror· 4 days agoVeeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its first quarter ended ...
